
Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2026
Global Outlook – By Component (Pumps, Oxygenator, Controllers, Cannula, Accessories), By Modality (Veno-Venous, Veno-Arterials, Arterio-Venous), By Patient Type (Neonates, Pediatric, Adult), By Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation(ECPR)), By End Use (Hospitals, Ambulatory Surgical Centers, Research Institutions) - Market Size, Trends, And Global Forecast 2026-2035
Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Overview
• Extracorporeal Membrane Oxygenation Machine (ECMO) Machine market size has reached to $1.15 billion in 2025 • Expected to grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Lung Transplant Procedures To Propel Growth In The Market • Market Trend: Innovations in Extracorporeal Membrane Oxygenation (ECMO) Machines • North America was the largest region in 2025.What Is Covered Under Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market?
An extracorporeal membrane oxygenation (ECMO) machine refers to a specialized medical device that provides cardiac and respiratory support by oxygenating blood outside the body. It is used for patients experiencing severe heart or lung failure, offering critical support in life-threatening conditions. The main components of an extracorporeal membrane oxygenation (ECMO) machine are pumps, oxygenators, controllers, cannulas, and accessories. ECMO pumps are devices that circulate blood through the oxygenator, assisting in maintaining blood flow during respiratory or cardiac failure. They are crucial in maintaining adequate circulation during ECMO procedures. The modalities used in ECMO include veno-venous (VV), veno-arterial (VA), and arterio-venous (AV) configurations, each serving different clinical needs. The various patient types include neonates, pediatrics, and adults, and it is applied in the treatment of respiratory and cardiac conditions. The various end users of ECMO machines include hospitals, ambulatory surgical centers, and research institutions.
What Is The Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Size and Share 2026?
The extracorporeal membrane oxygenation machine (ecmo) machine market size has grown strongly in recent years. It will grow from $1.15 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of respiratory failure, growth in cardiac disorders, expansion of intensive care units, rising use during pandemics, advancements in life-support technologies.What Is The Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Growth Forecast?
The extracorporeal membrane oxygenation machine (ecmo) machine market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to technological advancements in oxygenators, rising investment in critical care infrastructure, increasing neonatal survival rates, expansion of mobile ecmo adoption, growing training programs for ecmo specialists. Major trends in the forecast period include rising use in critical care and emergency settings, growing adoption in neonatal and pediatric care, expansion of mobile ecmo systems, increased focus on advanced life support, growth in specialized ecmo centers.Global Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Segmentation
1) By Component: Pumps, Oxygenator, Controllers, Cannula, Accessories 2) By Modality: Veno-Venous, Veno-Arterials, Arterio-Venous 3) By Patient Type: Neonates, Pediatric, Adult 4) By Application: Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation(ECPR) 5) By End Use: Hospitals, Ambulatory Surgical Centers, Research Institutions Subsegments: 1) By Pumps: Roller Pumps, Centrifugal Pumps 2) By Oxygenator: Hollow Fiber Oxygenators, Flat Sheet Oxygenators, Pediatric Oxygenators 3) By Controllers: Analog Controllers, Digital Controllers, Mobile ECMO Controllers 4) By Cannula: Venous Cannula, Arterial Cannula, Bi-Caval Dual Lumen Cannula 5) By Accessories: Tubing Sets, Blood Filters, Temperature Probes, HemoconcentratorsWhat Is The Driver Of The Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market?
The rise in lung transplant procedures is expected to propel the growth of the extracorporeal membrane oxygenation machine (ECMO) machine market going forward. A lung transplant is a surgical procedure in which a diseased or damaged lung is replaced with a healthy lung from a donor. Lung transplants are rising due to improved surgical techniques, better post-transplant care, and a growing organ donor pool, leading to increased success rates and patient eligibility. Extracorporeal membrane oxygenation (ECMO) machine enhances the success rate of lung transplant procedures by providing life-saving support to patients with severe respiratory failure, allowing them to remain stable until a suitable donor lung becomes available. For instance, in January 2025, according to the Organ Procurement and Transplantation Network (OPTN), a US-based public-private partnership, lung transplants grew from 3,026 in 2023 to 3,340 in 2024, a 10.4% increase. Therefore, the rise in lung transplant procedures is driving the growth of the extracorporeal membrane oxygenation machine (ECMO) machine industry.Key Players In The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market
Major companies operating in the extracorporeal membrane oxygenation machine (ecmo) machine market are Abiomed Inc., Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Terumo Cardiovascular Systems Corporation, Shenzhen Mindray Biomedical Electronics Co. Ltd., Nipro Corporation, Getinge Group, LivaNova plc, MicroPort Scientific Corporation, Hamilton Medical AG, Braile Biomédica, Xenios AG, Eurosets S.R.L., OriGen Biomedical Inc., Hemovent GmbH, Senko Medical Instrument Mfg Co Ltd, Medos Medizintechnik AG, Spectrum Medical, Chalice MedicalGlobal Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Trends and Insights
Major companies operating in the extracorporeal membrane oxygenation machine (ECMO) machine market are focusing on developing innovative products such as configurable one-system ECMO solutions to enhance patient outcomes, streamline clinical workflows, and improve ease of use in critical care environments. A configurable one-system ECMO solution refers to a flexible ECMO machine that can be tailored to meet the specific needs of individual patients, offering customizable settings and components for optimal respiratory and cardiac support in various clinical scenarios. For instance, in September 2024, Medtronic plc, a US-based medical device company, launched VitalFlow, a configurable ECMO solution designed for simplicity and performance. This configurable, one-system solution is built on simplicity, allowing for streamlined setup and easy adjustments during critical care. It provides a high level of performance with advanced monitoring capabilities, ensuring optimal oxygenation and blood circulation management. The system is designed for flexibility, supporting both venovenous (VV) and venoarterial (VA) configurations, making it adaptable to a wide range of patient needs.What Are Latest Mergers And Acquisitions In The Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market?
In March 2024, Medtronic plc, a US-based medical device company, acquired MC3 Cardiopulmonary for an undisclosed amount. With the acquisition, Medtronic aims to expand its portfolio of advanced life-support solutions by integrating ECMO technologies, enhancing its capabilities in critical care, and providing more innovative products to support patients with severe heart and lung failure. MC3 Cardiopulmonary is a US-based company that specializes in the development and manufacturing of advanced medical devices, including extracorporeal membrane oxygenation (ECMO) systems.Regional Outlook
North America was the largest region in the extracorporeal membrane oxygenation machine (ECMO) machine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market?
The extracorporeal membrane oxygenation (ECMO) machine market consists of sales of advanced life-support systems, monitoring systems, blood pumps, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2026?
The extracorporeal membrane oxygenation machine (ecmo) machine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the extracorporeal membrane oxygenation machine (ecmo) machine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.24 billion |
| Revenue Forecast In 2035 | $1.69 billion |
| Growth Rate | CAGR of 8.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Modality, Patient Type, Application, End Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Abiomed Inc., Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Terumo Cardiovascular Systems Corporation, Shenzhen Mindray Biomedical Electronics Co. Ltd., Nipro Corporation, Getinge Group, LivaNova plc, MicroPort Scientific Corporation, Hamilton Medical AG, Braile Biomédica, Xenios AG, Eurosets S.R.L., OriGen Biomedical Inc., Hemovent GmbH, Senko Medical Instrument Mfg Co Ltd, Medos Medizintechnik AG, Spectrum Medical, Chalice Medical |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
